Statistical method for testing the neutral mutation hypothesis by DNA polymorphism.

We redescribe the only previously known species of Myrsidea from bulbuls, M. pycnonoti Eichler. Sixteen new species are described; they and their type hosts are: M. phillipsi ex Pycnonotus goiavier goiavier (Scopoli), M. gieferi ex P. goiavier suluensis Mearns, M. kulpai ex P. flavescens Blyth, M. finlaysoni ex P. finlaysoni Strickland, M. kathleenae ex P. cafer (L.), M. warwicki ex Ixos philippinus (J. R. Forster), M. mcclurei ex Microscelis amaurotis (Temminck), M. zeylanici ex P. zeylanicus (Gmelin), M. plumosi ex P. plumosus Blyth, M. eutiloti ex P. eutilotus (Jardine and Selby), M. adamsae ex P. urostictus (Salvadori), M. ochracei ex Criniger ochraceus F. Moore, M. borbonici ex Hypsipetes borbonicus (J. R. Forster), M. johnsoni ex P. atriceps (Temminck), M. palmai ex C. ochraceus, and M. claytoni ex P. eutilotus. A key is provided for the identification of these 17 species.

A new species

Advances in the last decade combining transcriptomics with established proteomics methods have made possible rapid identification and quantification of protein families in snake venoms. Although over 100 studies have been published, the value of this information is increased when it is collated, allowing rapid assimilation and evaluation of evolutionary trends, geographical variation, and possible medical implications. This review brings together all compositional studies of snake venom proteomes published in the last decade. Compositional studies were identified for 132 snake species: 42 from 360 (12%) Elapidae (elapids), 20 from 101 (20%) Viperinae (true vipers), 65 from 239 (27%) Crotalinae (pit vipers), and five species of non-front-fanged snakes. Approximately 90% of their total venom composition consisted of eight protein families for elapids, 11 protein families for viperines and ten protein families for crotalines. There were four dominant protein families: phospholipase A2s (the most common across all front-fanged snakes), metalloproteases, serine proteases and three-finger toxins. There were six secondary protein families: cysteine-rich secretory proteins, l-amino acid oxidases, kunitz peptides, C-type lectins/snaclecs, disintegrins and natriuretic peptides. Elapid venoms contained mostly three-finger toxins and phospholipase A2s and viper venoms metalloproteases, phospholipase A2s and serine proteases. Although 63 protein families were identified, more than half were present in <5% of snake species studied and always in low abundance. The importance of these minor component proteins remains unknown.

https://www.mdpi.com/2072-6651/9/9/290/pdf

A Review and Database of Snake Venom Proteomes

Treatment of acute renal failure

Phylogeny and polyploidy: Resolving the classification of cyprinine fishes (Teleostei: Cypriniformes)

Venomous snakebite is considered the single most important cause of human injury from venomous animals worldwide. Coagulopathy is one of the commonest important systemic clinical syndromes and can be complicated by serious and life-threatening haemorrhage. Venom-induced consumption coagulopathy (VICC) is the commonest coagulopathy resulting from snakebite and occurs in envenoming by Viperid snakes, certain elapids, including Australian elapids, and a few Colubrid (rear fang) snakes. Procoagulant toxins activate the clotting pathway, causing a broad range of factor deficiencies depending on the particular procoagulant toxin in the snake venom. Diagnosis and monitoring of coagulopathy is problematic, particularly in resource-poor countries where further research is required to develop more reliable, cheap clotting tests. MEDLINE and EMBASE up to September 2013 were searched to identify clinical studies of snake envenoming with VICC. The UniPort database was searched for coagulant snake toxins. Despite preclinical studies demonstrating antivenom binding toxins (efficacy), there was less evidence to support clinical effectiveness of antivenom for VICC. There were no placebo-controlled trials of antivenom for VICC. There were 25 randomised comparative trials of antivenom for VICC, which compared two different antivenoms (ten studies), three different antivenoms (four), two or three different doses or repeat doses of antivenom (five), heparin treatment and antivenom (five), and intravenous immunoglobulin treatment and antivenom (one). There were 13 studies that compared two groups in which there was no randomisation, including studies with historical controls. There have been numerous observational studies of antivenom in VICC but with no comparison group. Most of the controlled trials were small, did not use the same method for assessing coagulopathy, varied the dose of antivenom, and did not provide complete details of the study design (primary outcomes, randomisation, and allocation concealment). Non-randomised trials including comparison groups without antivenom showed that antivenom was effective for some snakes (e.g., Echis), but not others (e.g., Australasian elapids). Antivenom is the major treatment for VICC, but there is currently little high-quality evidence to support effectiveness. Antivenom is not risk free, and adverse reactions can be quite common and potentially severe. Studies of heparin did not demonstrate it improved outcomes in VICC. Fresh frozen plasma appeared to speed the recovery of coagulopathy and should be considered in bleeding patients.

/pdf/current-treatment-for-venom-induced-consumption-coagulopathy-52tzaq1l3l.pdf

Current treatment for venom-induced consumption coagulopathy resulting from snakebite.

The tropical Asian cyprinid genus Puntius, which contains some 120 valid species, has long been suspected to be polyphyletic. Here, through an examination of external morphology, osteology, and analysis of 16S ribosomal RNA and cytochrome b gene fragments from 31 South Asian species hitherto referred to Puntius, we show that these fishes represent at least five lineages recognisable as genera. Puntius sensu stricto has the rostral barbels absent; last unbranched dorsal-fin ray weak or strong, smooth; and lateral line complete, with 22-28 pored scales. Systomus possesses maxillary and rostral barbels; last unbranched dorsal-fin ray stiff (‘osseous’), serrated; and lateral line complete, with 27-34 scales. Three new genera are proposed: Dawkinsia (type species Leuciscus fila­ mentosus) is distinguished by lacking rostral barbels; having the last unbranched dorsal-fin ray smooth; lateral line complete, with 18-22 scales; and a juvenile colour pattern that includes three black bars on the body. Dra­ vidia (type species Cirrhinus fasciatus) is distinguished by having both rostral and maxillary barbels present; lateral line complete, with 18–26 pored scales; dorsal fin with 4 unbranched and 8 branched rays, last unbranched dorsal-fin ray smooth; infraorbital 3 deep, partly overlapping the preoperculum; and free uroneural and postepiphysial fontanelle absent. Pethia (type species Barbus nigrofasciatus) is distinguished by having the last unbranched dorsal-fin ray stiff, serrated; infraorbital 3 deep, partially overlapping preoperculum; rostral barbels absent; maxillary barbels absent or minute; a black blotch on the caudal peduncle; and frequently, black blotches, spots or bars on the side of the body. The identities of Puntius sophore and Systomus immaculatus are clarified through the designation of neotypes; a lectotype is designated for Neolissochilus bovanicus; and precedence is given to the spelling bovanicus over bovianicus.

A synopsis of the South Asian fishes referred to Puntius (Pisces: Cyprinidae)

Background: The 20-min whole blood clotting test (WBCT20) is widely used for the identification of coagulopathy in snake envenoming, but its performance in practice has not been evaluated.

Aim: We aimed to investigate the diagnostic utility of the WBCT20 for coagulopathy in Russell’s viper envenoming.

Design: Prospective observational study.

Methods: Adult patients with snake envenoming were recruited. Age, sex, bite information, clinical effects, serial WBCT20 and antivenom treatment were recorded. Definite Russell’s viper envenoming was confirmed with venom specific enzyme immunoassay. We assessed sensitivity of admission WBCT20 to coagulopathy (international normalized ratio, INR > 1.5) in Russell’s viper envenoming, the specificity of negative WBCT20 in non-envenomed patients and directly compared paired WBCT20 and INR.

Results: Admission WBCT20 was done in 140 Russell’s viper bites with coagulopathy and was positive in 56/140 [sensitivity 40% (95% confidence interval (CI): 32–49%)]. A negative WBCT20 led to delayed antivenom administration [WBCT20−ve tests: median delay, 1.78 h (interquartile range (IQR): 0.83–3.7 h) vs. WBCT20 + ve tests: median delay, 0.82 h (IQR: 0.58–1.48 h); P = 0.0007]. Delays to antivenom were largely a consequence of further WBCT20 being performed and more common if the first test was negative (41/84 vs. 12/56). Initial WBCT20 was negative in 9 non-envenomed patients and 48 non-venomous snakebites [specificity: 100% (95% CI: 94–100%)]. In 221 paired tests with INR > 1.5, the WBCT20 was positive in 91(41%). The proportion of positive WBCT20 only increased slightly with higher INR.

Conclusions: In clinical practice, the WBCT20 has low sensitivity for detecting coagulopathy in snake envenoming and should not over-ride clinical assessment-based decisions about antivenom administration. There is an urgent need to develop a simple bedside test for coagulopathy in snake envenoming.

Diagnostic 20-min whole blood clotting test in Russell's viper envenoming delays antivenom administration

Epidemiology and clinical effects of hump-nosed pit viper (Genus: Hypnale) envenoming in Sri Lanka

The hump-nosed pit vipers of the genus Hypnale are of substantial medical importance in Sri Lanka and India, being included among the five snakes most frequently associated with life-threatening envenoming in humans. The genus has hitherto been considered to comprise three species: H. hypnale, common to Sri Lanka and the Western Ghats of peninsular India; and H. nepa and H. walli, both of which are endemic to Sri Lanka. The latter two species have frequently been confused in the literature. Here, through a review of all extant name-bearing types in the genus, supplemented by examination of preserved specimens, we show that H. nepa is restricted to the higher elevations of Sri Lanka’s central mountains; that H. walli is a junior synonym of H. nepa; and that the endemic species widely distributed in the island’s south-western ‘wet-zone’ lowlands is H. zara. We also draw attention to a possibly new species known only from a single specimen collected near Galle in southern Sri Lanka. We illustrate all four species in colour, and provide a key to their identification and maps delineating their distribution.

Kalana Maduwage

Papers

Current treatment for venom-induced consumption coagulopathy resulting from snakebite.

A synopsis of the South Asian fishes referred to Puntius (Pisces: Cyprinidae)

Diagnostic 20-min whole blood clotting test in Russell's viper envenoming delays antivenom administration

Epidemiology and clinical effects of hump-nosed pit viper (Genus: Hypnale) envenoming in Sri Lanka

A taxonomic revision of the South Asian hump-nosed pit vipers (Squamata: Viperidae: Hypnale)